Wedbush Securities’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-210,914
| Closed | -$17K | – | 961 |
|
|
2018
Q2 | $17K | Buy |
210,914
+150,000
| +246% | +$12.1K | ﹤0.01% | 870 |
|
|
2018
Q1 | $19K | Sell |
60,914
-14,738
| -19% | -$4.6K | ﹤0.01% | 809 |
|
|
2017
Q4 | $125K | Buy |
75,652
+1,888
| +3% | +$3.12K | 0.02% | 773 |
|
|
2017
Q3 | $106K | Buy |
73,764
+31,800
| +76% | +$45.7K | 0.01% | 776 |
|
|
2017
Q2 | $68K | Buy |
41,964
+32,126
| +327% | +$52.1K | 0.01% | 788 |
|
|
2017
Q1 | $33K | Buy |
+9,838
| New | +$33K | ﹤0.01% | 819 |
|